Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 5Interventional 3

Sponsor

Conditions

Arthritis, Rheumatoid 5Inflammatory Bowel Diseases 2Colitis, Ulcerative 2Spondylitis, Ankylosing 1Psoriasis 1Precancerous Conditions 1Melanoma 1Infections 1Hepatitis C 1Crohn Disease 1Arthritis 1

Interventions

Etanercept 6Adalimumab 6Infliximab 5tocilizumab 3golimumab 3Tumor Necrosis Factor Inhibitors 3tofacitinib 2Rituximab 2Certolizumab Pegol 2Surveys and Questionnaires 1Standard of Care 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1CT-P13 1Antirheumatic Agents 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Arthritis, Rheumatoid × Infliximab × Clear all
NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

NCT05379049 2022-05-18

TNF-alpha

University of Sulaimani

Unknown
80 enrolled

Arthritis, Arthritis, Rheumatoid, Spondylitis, Ankylosing

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02778789 2019-09-26

Re-Bone

University of Erlangen-Nürnberg Medical School

Completed
66 enrolled

Arthritis, Rheumatoid

NCT00724672 2015-06-01

A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

Merck Sharp & Dohme LLC

Withdrawn

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡